Another company is DOE approved for matching funding as it enters the Mo-99 market.
Recently, the Department of Energy’s National Nuclear Security Administration (NNSA) issued a cooperative agreement with the fourth U.S. company for the production of Mo-99 without highly enriched uranium. The company located in Corvallis, Oregon, Northwest Medical Isotopes received a commitment of $15 million in matching funds from the DOE’s NNSA. Previously agreements were reached with three other U.S. companies, Niowave (Lansing, Michigan), NorthStar Medical Radioisotopes (Beloit, Wisconsin) and SHINE Medical Technologies (Janesville, Wisconsin). Adding another company to the list for the production of Mo-99 here in the USA is a good sign that we are moving forward to secure a
Three companies received DOE cooperative agreements to produce Mo-99 in the U.S.
$15 million matching grant funding offers were provided to three companies, Niowave, Inc., in Lansing, Michigan, NorthStar Medical Radioisotopes, LLC, in Beloit, Wisconsin and SHINE Medical Technologies, located in Janesville, Wisconsin. Lisa E. Gordon-Hagerty, DOE undersecretary for nuclear security and NNSA administrator, said in a statement, “These agreements will facilitate its [the United States] domestic production without highly enriched uranium, greatly reducing the potential for proliferation of nuclear materials.” One other company is negotiating with DOE for a similar matching grant. Link: https://www.healthimaging.com/topics/molecular-imaging/department-energy-awards-3-us-companies-mo-99